IP Library Assignment 075713/0146
Patent Assignment
Reel/Frame 075713/0146

Assignment of Assignor's Interest

Recorded: 2026-05-22 Pages: 29
Assignor
THERAKOS DEVELOPMENT LIMITED
Executed: 2026-03-16
Assignee
THERAKOS HOLDINGS USA, LLC
1170 ROUTE 22 EAST, SUITE 102, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties (32)
Adiponectin Alone or in Combination with Extracorporeal Photopheresis (Ecp) for Immune Related Adverse Events of Immune Checkpoint Inhibitors
Application: 63/517,685 →
Adiponectin Alone or in Combination with Extracorporeal Photopheresis (Ecp) for Immune Related Adverse Events of Immune Checkpoint Inhibitors
Application: 18/392,250 →
Publication: US US20240307497A1
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Patent: 7,914,477 →
Application: 11/406,988 →
Publication: US US20060186061A1
Centrifuge System and Method with Component Tracking
Application: 15/261,968 →
Centrifuge System and Method with Component Tracking
Application: 16/537,103 →
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Application: 16/906,976 →
Publication: US US20200316285A1
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Application: 15/737,163 →
Publication: US US20180154066A1
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Application: 18/640,626 →
Publication: US US20240261488A1
Method and Apparatus for Collecting a Blood Component and Performing a Photopheresis Treatment
Patent: 7,476,209 →
Application: 11/304,092 →
Publication: US US20060155236A1
Method and Apparatus for the Continuous Separation of Biological Fluids into Components
Patent: 7,186,230 →
Application: 10/375,629 →
Publication: US US20030181305A1
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Patent: 7,479,123 →
Application: 10/654,803 →
Publication: US US20040127841A1
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Patent: 7,850,634 →
Application: 11/613,021 →
Publication: US US20070100272A1
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Application: 18/584,070 →
Publication: US US20240191193A1
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Application: 15/981,332 →
Publication: US US20180258393A1
Method for Generating Immunoregulatory Cells in a Blood-Derived Sample
Application: 17/787,836 →
Publication: US US20230024405A1
Method for Generating Immunoregulatory Cells in a Blood-Derived Sample
Application: 19/383,352 →
Publication: US US20260061057A1
Method of Extracorporeal Photopheresis for Immune-Related Adverse Events
Application: 18/103,202 →
Publication: US US20230165961A1
Phototherapy Compositions and Methods
Patent: 8,057,785 →
Application: 11/311,714 →
Publication: US US20060134031A1
Phototherapy Compositions and Methods
Patent: 8,481,008 →
Application: 13/243,103 →
Publication: US US20120039825A1
Processing Blood
Application: 17/176,013 →
Publication: US US20210187181A1
Processing Blood
Application: 15/066,659 →
Publication: US US20160339165A1
Processing Blood
Application: 13/738,039 →
Publication: US US20140030238A1
Processing Blood
Application: 12/628,303 →
Publication: US US20100210989A1
Processing Blood
Application: 15/974,881 →
Publication: US US20180256806A1
Processing Blood
Application: 16/171,089 →
Publication: US US20190060548A1
Processing Blood
Application: 16/171,096 →
Publication: US US20190060549A1
Processing Blood
Application: 19/299,923 →
Publication: US US20260027278A1
Support for Centrifuge Tubing
Application: 15/570,996 →
Publication: US US20180299030A1
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Patent: 9,169,461 →
Application: 11/579,319 →
Publication: US US20080267934A1
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Application: 14/863,274 →
Publication: US US20160046909A1
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Application: 16/165,679 →
Publication: US US20190055516A1
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Application: 17/458,206 →
Publication: US US20210388318A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 16, 2003
From: BRIGGS, DENNIS A.; HUTCHINSON, MICHAEL
To: THERAKOS, INC.
Reel/Frame 013659/0227 →
Assignment of Assignor's Interest Dec 15, 2005
From: GARA, STEPHEN; STAR, CYNTHIA; BRIGGS, DENNIS; HUTCHINSON, MICHAEL
To: THERAKOS, INC
Reel/Frame 017370/0627 →
Assignment of Assignor's Interest Dec 19, 2005
From: DECOLA, DENNIS; COLE, CURTIS
To: OMJ IRELAND LIMITED
Reel/Frame 017367/0291 →
Assignment of Assignor's Interest Nov 11, 2006
From: BRIGGS, DENNIS; GARA, STEVE; WATTERS, TOM; HUTCHINSON, MICHAEL
To: THERAKOS, INC.
Reel/Frame 018508/0673 →
Assignment of Assignor's Interest Dec 19, 2006
From: BRIGGS, DENNIS
To: THERAKOS, INC.
Reel/Frame 018653/0922 →
Assignment of Assignor's Interest Dec 19, 2006
From: BRIGGS, DENNIS
To: THERAKOS, INC
Reel/Frame 018655/0588 →
Intellectual Property Security Agreement (Second Lien) Dec 28, 2012
From: THERAKOS, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 029549/0119 →
Intellectual Property Security Agreement (First Lien) Dec 28, 2012
From: THERAKOS, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 029549/0074 →
Merger Jan 25, 2013
From: TGG MEDICAL TRANSITORY, INC.
To: THERAKOS, INC.
Reel/Frame 029692/0545 →
Assignment of Assignor's Interest Jan 25, 2013
From: OMJ IRELAND
To: TGG MEDICAL TRANSITORY, INC.
Reel/Frame 029692/0421 →
Assignment of Assignor's Interest Sep 16, 2013
From: DECOLA, DENNIS; COLE, CURTIS
To: OMJ IRELAND LIMITED
Reel/Frame 031208/0942 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 29549/0119 Sep 25, 2015
From: ROYAL BANK OF CANADA
To: THERAKOS, INC.
Reel/Frame 036688/0863 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 29549/0074 Sep 25, 2015
From: ROYAL BANK OF CANADA
To: THERAKOS, INC.
Reel/Frame 036688/0833 →
Security Interest Sep 25, 2015
From: THERAKOS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 036662/0053 →
Assignment of Assignor's Interest Mar 5, 2016
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING DAC
Reel/Frame 038038/0009 →
Assignment of Assignor's Interest Mar 5, 2016
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 038009/0016 →
Assignment of Assignor's Interest Mar 5, 2016
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 038008/0824 →
Assignment of Assignor's Interest Mar 5, 2016
From: MALLINCKRODT PHARMA IP TRADING DAC
To: MALLINCKRODT IP
Reel/Frame 038009/0058 →
Notice of Grant of Security Interest in Patents Aug 18, 2017
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 043601/0025 →
Assignment of Assignor's Interest Jul 6, 2018
From: BRIGGS, DENNIS; DO, SIMON; VANDLIK, MARK; MURPHY, KEVIN
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 046280/0436 →
Nunc Pro Tunc Assignment Jul 1, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049643/0397 →
Nunc Pro Tunc Assignment Jul 1, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 049643/0168 →
Nunc Pro Tunc Assignment Jul 1, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049643/0282 →
Nunc Pro Tunc Assignment Jul 1, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 049643/0348 →
Notice of Grant of Security Interest in Intellectual Property Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →